On average, 78 Canadians will be diagnosed with lung cancer every day1Non-small cell lung cancer is the most common form of lung cancer, making up 80 to 85% of all cases2The five-year relative survival rate for patients...
On average, 78 Canadians will be diagnosed with lung cancer every day1Non-small cell lung cancer is the most common form of lung cancer, making up 80 to 85% of all cases2The five-year relative survival rate for patients...
The U.S. Food and Drug Administration today cleared the first duodenoscope with a disposable distal cap, a new feature that will improve access for cleaning and reprocessing. The Pentax ED34-i10T model duodenoscope is...
The U.S. Food and Drug Administration today cleared the first duodenoscope with a disposable distal cap, a new feature that will improve access for cleaning and reprocessing. The Pentax ED34-i10T model duodenoscope is...
B.E. Smith is once again the top-ranked healthcare executive search firm in the United States. Modern Healthcare's 2017 annual report ranked the top 25 recruitment firms by number of senior-level healthcare executive...
B.E. Smith is once again the top-ranked healthcare executive search firm in the United States. Modern Healthcare's 2017 annual report ranked the top 25 recruitment firms by number of senior-level healthcare executive...
The "The Global Market for Pain Management Drugs and Devices" report has been added to Research and Markets' offering. The Global Market for Pain Management will Grow from Nearly $36.1 Billion in 2017 to $52.0...
The "The Global Market for Pain Management Drugs and Devices" report has been added to Research and Markets' offering. The Global Market for Pain Management will Grow from Nearly $36.1 Billion in 2017 to $52.0...
Immunotherapy, Chemotherapy, Targeted Therapy, Hormone Therapy, Leading Drugs The world cancer-treating drugs market is expected to grow at a CAGR of 6.6% in the second half of the forecast period. The market reached...
Immunotherapy, Chemotherapy, Targeted Therapy, Hormone Therapy, Leading Drugs The world cancer-treating drugs market is expected to grow at a CAGR of 6.6% in the second half of the forecast period. The market reached...
Therap's Medication Administration Recording tool is now available on the Therap iOS mobile application. The MAR mobile app for iPhone and iPads allows nurses, caregivers and med passers with their daily documentation...
Therap's Medication Administration Recording tool is now available on the Therap iOS mobile application. The MAR mobile app for iPhone and iPads allows nurses, caregivers and med passers with their daily documentation...
Arbor Pharmaceuticals, LLC, a U.S.-based specialty pharmaceutical company, announced today that Nymalize® (nimodipine) Oral Solution will now be available in a 10 mL (30 mg) unit dose cup. This new packaging option is...
Arbor Pharmaceuticals, LLC, a U.S.-based specialty pharmaceutical company, announced today that Nymalize® (nimodipine) Oral Solution will now be available in a 10 mL (30 mg) unit dose cup. This new packaging option is...
DarioHealth Corp. (NASDAQ: DRIO), a smart diabetes solution, and HighTechXL, a corporate-backed accelerator based in Eindhoven, The Netherlands, announce their strategic collaboration to bring personalized healthcare...
DarioHealth Corp. (NASDAQ: DRIO), a smart diabetes solution, and HighTechXL, a corporate-backed accelerator based in Eindhoven, The Netherlands, announce their strategic collaboration to bring personalized healthcare...
The "USA In-Vitro Diagnostics Market - Growth, Trends & Forecast 2017 - 2022" report has been added to Research and Markets' offering. The USA's market for In-Vitro Diagnostics is currently estimated to be...
The "USA In-Vitro Diagnostics Market - Growth, Trends & Forecast 2017 - 2022" report has been added to Research and Markets' offering. The USA's market for In-Vitro Diagnostics is currently estimated to be...
The "China Contraceptive Devices Market Growth, Trends & Forecast 2017 - 2022" report has been added to Research and Markets' offering. The China market for contraceptive devices is estimated to be valued as...
The "China Contraceptive Devices Market Growth, Trends & Forecast 2017 - 2022" report has been added to Research and Markets' offering. The China market for contraceptive devices is estimated to be valued as...
Over the course of the last few years we have seen significant gains in life changing cancer therapies. These gains in cancer science are set to continue to be more frequent, and significant. Biotechnology companies that...
Over the course of the last few years we have seen significant gains in life changing cancer therapies. These gains in cancer science are set to continue to be more frequent, and significant. Biotechnology companies that...
Industry professionals are reporting that sales growth estimates for the legal marijuana, hemp and cannabis industry are reaching new highs every day. The Marijuana Business Daily's newest report, "Marijuana Business...
Industry professionals are reporting that sales growth estimates for the legal marijuana, hemp and cannabis industry are reaching new highs every day. The Marijuana Business Daily's newest report, "Marijuana Business...
Northwest Biotherapeutics (OTCQB: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today announced that it has entered into definitive agreements with...
Northwest Biotherapeutics (OTCQB: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today announced that it has entered into definitive agreements with...
DURECT Corporation (Nasdaq: DRRX) announced today that Dr. Myriam Theeuwes has joined DURECT as Senior Vice President, Clinical Development. Dr. Theeuwes joins DURECT from Johnson & Johnson where she spent 18 years,...
DURECT Corporation (Nasdaq: DRRX) announced today that Dr. Myriam Theeuwes has joined DURECT as Senior Vice President, Clinical Development. Dr. Theeuwes joins DURECT from Johnson & Johnson where she spent 18 years,...
BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies with a first in class collagenase-based product marketed as XIAFLEX® in the...
BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies with a first in class collagenase-based product marketed as XIAFLEX® in the...
Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) (Aldeyra), a clinical-stage biotechnology company devoted to treating inflammation, inborn errors of metabolism, and other diseases related to endogenous aldehyde toxicity, today...
Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) (Aldeyra), a clinical-stage biotechnology company devoted to treating inflammation, inborn errors of metabolism, and other diseases related to endogenous aldehyde toxicity, today...
Five colleges and universities in Texas have received grants to advocate for, adopt and implement 100 percent smoke- and tobacco-free policies on their campuses. These schools include:
Five colleges and universities in Texas have received grants to advocate for, adopt and implement 100 percent smoke- and tobacco-free policies on their campuses. These schools include:
Four colleges and universities in Tennessee have received grants to advocate for, adopt and implement 100 percent smoke- and tobacco-free policies on their campuses. These schools include:
Four colleges and universities in Tennessee have received grants to advocate for, adopt and implement 100 percent smoke- and tobacco-free policies on their campuses. These schools include:
Six colleges and universities in Ohio have received grants to advocate for, adopt and implement 100 percent smoke- and tobacco-free policies on their campuses. These schools include:
Six colleges and universities in Ohio have received grants to advocate for, adopt and implement 100 percent smoke- and tobacco-free policies on their campuses. These schools include:
Ten colleges and universities in North Carolina have received grants to advocate for, adopt and implement 100 percent smoke- and tobacco-free policies on their campuses. These schools include:
Ten colleges and universities in North Carolina have received grants to advocate for, adopt and implement 100 percent smoke- and tobacco-free policies on their campuses. These schools include:
Five colleges and universities in New York have received to advocate for, adopt and implement 100 percent smoke- and tobacco-free policies on their campuses. These schools include:
Five colleges and universities in New York have received to advocate for, adopt and implement 100 percent smoke- and tobacco-free policies on their campuses. These schools include:
Twenty-one colleges and universities in California have received grants to advocate for, adopt and implement 100 percent smoke- and tobacco-free policies on their campuses. These schools include:
Twenty-one colleges and universities in California have received grants to advocate for, adopt and implement 100 percent smoke- and tobacco-free policies on their campuses. These schools include:
Trovagene, Inc. (NASDAQ: TROV), a precision medicine biotechnology company, today announced the expansion and strengthening of its Board of Directors with the appointment of Athena Countouriotis, M.D.
Trovagene, Inc. (NASDAQ: TROV), a precision medicine biotechnology company, today announced the expansion and strengthening of its Board of Directors with the appointment of Athena Countouriotis, M.D.
Arvinas LLC, a private biotechnology company creating a new class of drugs based on protein degradation, today announced the appointment of John Houston, Ph.D., as president and chief executive officer. Dr. Houston will...
Arvinas LLC, a private biotechnology company creating a new class of drugs based on protein degradation, today announced the appointment of John Houston, Ph.D., as president and chief executive officer. Dr. Houston will...
Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases and cancer, today announced that...
Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases and cancer, today announced that...
Nektar Therapeutics (Nasdaq: NKTR) today announced that new data across its wholly-owned immuno-oncology (I-O) portfolio will be presented at the upcoming Society for Immunotherapy of Cancer (SITC) Annual Meeting, which is...
Nektar Therapeutics (Nasdaq: NKTR) today announced that new data across its wholly-owned immuno-oncology (I-O) portfolio will be presented at the upcoming Society for Immunotherapy of Cancer (SITC) Annual Meeting, which is...
Roivant Sciences, a global healthcare company focused on realizing the full value of promising biomedical research to improve the lives of patients and their families, today announced the launch of Datavant, a new company...
Roivant Sciences, a global healthcare company focused on realizing the full value of promising biomedical research to improve the lives of patients and their families, today announced the launch of Datavant, a new company...
Protagonist Therapeutics, Inc. (Nasdaq: PTGX) today announced preliminary results from the Phase 1 study of PTG-300 in normal healthy volunteers. PTG-300 is an injectable hepcidin mimetic peptide, discovered using the...
Protagonist Therapeutics, Inc. (Nasdaq: PTGX) today announced preliminary results from the Phase 1 study of PTG-300 in normal healthy volunteers. PTG-300 is an injectable hepcidin mimetic peptide, discovered using the...
AOBiome, a clinical-stage life sciences company advancing patented microbiome-targeted therapies for systemic and local inflammatory conditions, today announced that the United States Patent and Trademark Office (USPTO)...
AOBiome, a clinical-stage life sciences company advancing patented microbiome-targeted therapies for systemic and local inflammatory conditions, today announced that the United States Patent and Trademark Office (USPTO)...
Eight colleges and universities in Mississippi have received grants to advocate for, adopt and implement 100 percent smoke- and tobacco-free policies on their campuses. These schools include:
Eight colleges and universities in Mississippi have received grants to advocate for, adopt and implement 100 percent smoke- and tobacco-free policies on their campuses. These schools include:
The United States International Trade Commission announced in a press release that it has voted to institute an investigation of certain periodontal laser devices and components thereof. The investigation follows...
The United States International Trade Commission announced in a press release that it has voted to institute an investigation of certain periodontal laser devices and components thereof. The investigation follows...
MONTREAL, Sept. 20, 2017 /CNW Telbec/ - Pendopharm, a division of Pharmascience Inc. announces today its investment in Ontario based Edesa Biotech Inc., a clinical-stage private company, following Edesa Biotech Inc.'s...
MONTREAL, Sept. 20, 2017 /CNW Telbec/ - Pendopharm, a division of Pharmascience Inc. announces today its investment in Ontario based Edesa Biotech Inc., a clinical-stage private company, following Edesa Biotech Inc.'s...
Eye care and eyewear are not usually top of mind following a natural disaster, but rebuilding your life in the aftermath when you can't see clearly can make it even more difficult. VSP Global is committed to providing...
Eye care and eyewear are not usually top of mind following a natural disaster, but rebuilding your life in the aftermath when you can't see clearly can make it even more difficult. VSP Global is committed to providing...
Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced...
Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced...
Luminex Corporation (NASDAQ: LMNX) today announced that management will present at Cantor Fitzgerald's Global Healthcare Conference to be held September 25 -27, 2017, in New York, NY.
Luminex Corporation (NASDAQ: LMNX) today announced that management will present at Cantor Fitzgerald's Global Healthcare Conference to be held September 25 -27, 2017, in New York, NY.
Theravance Biopharma, Inc. (NASDAQ: TBPH) announced today that members of management will present a corporate overview at the Cantor Fitzgerald Global Healthcare Conference on Tuesday, September 26, 2017 at 9:10 a.m. ET....
Theravance Biopharma, Inc. (NASDAQ: TBPH) announced today that members of management will present a corporate overview at the Cantor Fitzgerald Global Healthcare Conference on Tuesday, September 26, 2017 at 9:10 a.m. ET....
MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts and patent-protected processes for...
MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts and patent-protected processes for...
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@franklyinc.com SOURCE Research and Markets DUBLIN, September 19, 2017 /PRNewswire/ -- The "Developments in Image-Guided Therapy, Forecast to 2020" report has been added to Research and Markets' offering. Me...
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@franklyinc.com SOURCE Research and Markets DUBLIN, September 19, 2017 /PRNewswire/ -- The "Developments in Image-Guided Therapy, Forecast to 2020" report has been added to Research and Markets' offering. Me...
goBalto, Inc., the leading provider of cloud-based clinical study startup (SSU) solutions, has been named a finalist in the 'Best Technological Development in Clinical Trials - Sponsor-Focused' category for the...
goBalto, Inc., the leading provider of cloud-based clinical study startup (SSU) solutions, has been named a finalist in the 'Best Technological Development in Clinical Trials - Sponsor-Focused' category for the...
TORONTO, Sept. 19, 2017 /CNW/ - Cannabis Compliance Inc., (CCI) of Toronto, Ontario, Canada, is pleased to announce the formation of a strategic partnership with 3|Sixty Secure Corp. of Ottawa, Ontario, Canada, to provide...
TORONTO, Sept. 19, 2017 /CNW/ - Cannabis Compliance Inc., (CCI) of Toronto, Ontario, Canada, is pleased to announce the formation of a strategic partnership with 3|Sixty Secure Corp. of Ottawa, Ontario, Canada, to provide...
The Crohn's & Colitis Foundation and Oxford University Press announced today that they have entered into a new partnership to publish the Foundation's journal Inflammatory Bowels Diseases® beginning in 2018.
The Crohn's & Colitis Foundation and Oxford University Press announced today that they have entered into a new partnership to publish the Foundation's journal Inflammatory Bowels Diseases® beginning in 2018.
On September 14th, the three-day Fourth World Nobel Prize Laureate Summit 2017 was kicked off at the Guiyang International Eco-conference Center. Five Nobel Prize laureates, more than ten academicians from China and the...
On September 14th, the three-day Fourth World Nobel Prize Laureate Summit 2017 was kicked off at the Guiyang International Eco-conference Center. Five Nobel Prize laureates, more than ten academicians from China and the...
The international technology group Körber seeks to further strengthen its Business Area Pharma Systems with the acquisition of system partner Systec & Services GmbH. The aim of the acquisition is to strengthen existing...
The international technology group Körber seeks to further strengthen its Business Area Pharma Systems with the acquisition of system partner Systec & Services GmbH. The aim of the acquisition is to strengthen existing...
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), announced today that the European Commission has approved XERMELO® (telotristat ethyl) 250 mg as a first and only orally administered therapy for the treatment of carcinoid...
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), announced today that the European Commission has approved XERMELO® (telotristat ethyl) 250 mg as a first and only orally administered therapy for the treatment of carcinoid...
Absorption Systems, a global leader in translational medicine and pharmacokinetic testing of drugs, announces a formal Research Collaboration Agreement (RCA) with the U.S. Food and Drug Administration (FDA). The goals are...
Absorption Systems, a global leader in translational medicine and pharmacokinetic testing of drugs, announces a formal Research Collaboration Agreement (RCA) with the U.S. Food and Drug Administration (FDA). The goals are...
Penn State today announced that CSL Behring, a global specialty biotherapeutics leader, has committed $4.92 million to Penn State over the next six years to create the multidisciplinary Center of Excellence in...
Penn State today announced that CSL Behring, a global specialty biotherapeutics leader, has committed $4.92 million to Penn State over the next six years to create the multidisciplinary Center of Excellence in...
According to a new market research report "Microbial Identification Market by Product & Service (Instruments, Consumables, Identification Services), Method (Phenotypic, Proteomics-based, Genotypic), Application...
According to a new market research report "Microbial Identification Market by Product & Service (Instruments, Consumables, Identification Services), Method (Phenotypic, Proteomics-based, Genotypic), Application...
The Bio-Process Systems Alliance (BPSA), the national trade association of the single-use bio-processing industry, is pleased to announce that North Carolina State's Biomanufacturing Training & Education Center...
The Bio-Process Systems Alliance (BPSA), the national trade association of the single-use bio-processing industry, is pleased to announce that North Carolina State's Biomanufacturing Training & Education Center...
Digital health leaders, venture capitalists, and technology innovators will assemble on Monday, October 23 in Palo Alto to discuss opportunities and obstacles in digital health diffusion at the inaugural 2017 HITLAB...
Digital health leaders, venture capitalists, and technology innovators will assemble on Monday, October 23 in Palo Alto to discuss opportunities and obstacles in digital health diffusion at the inaugural 2017 HITLAB...
The American Chronic Pain Association asks people to "not just sit there" and "Give a Squat 4 Pain" in honor this month of Pain Awareness Month. To view an infographic in support of "Squat 4 Pain", please click here.
The American Chronic Pain Association asks people to "not just sit there" and "Give a Squat 4 Pain" in honor this month of Pain Awareness Month. To view an infographic in support of "Squat 4 Pain", please click here.
When it comes to male reproductive fertility, timing is everything. Now scientists are finding new details on how disruption of this timing may contribute to male infertility or congenital illness.
When it comes to male reproductive fertility, timing is everything. Now scientists are finding new details on how disruption of this timing may contribute to male infertility or congenital illness.
AIVITA Biomedical today announced the discovery of a new method for capturing and using intercellular signaling molecules to induce the reactivation of stem cell niches. The implication of this discovery is the ability to...
AIVITA Biomedical today announced the discovery of a new method for capturing and using intercellular signaling molecules to induce the reactivation of stem cell niches. The implication of this discovery is the ability to...
MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts with patent-protected processes for...
MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts with patent-protected processes for...
Morphotek®, Inc., a subsidiary of Eisai Inc., announced today that it will present preclinical data on its investigational antibody-drug conjugate (ADC) MORAb-202 at the 8th Annual World ADC being held September 20-22 at...
Morphotek®, Inc., a subsidiary of Eisai Inc., announced today that it will present preclinical data on its investigational antibody-drug conjugate (ADC) MORAb-202 at the 8th Annual World ADC being held September 20-22 at...
Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company, announced today a partnership with Sphaera Pharma to develop a new and proprietary analog of QBM-001 for pediatric developmental nonverbal disorder. "The...
Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company, announced today a partnership with Sphaera Pharma to develop a new and proprietary analog of QBM-001 for pediatric developmental nonverbal disorder. "The...
The "Stationary Oxygen Concentrators: Market Shares, Strategies, and Forecasts, Worldwide 2017 - 2023" report from Wintergreen Research, Inc has been added to Research and Markets' offering. Stationary oxygen...
The "Stationary Oxygen Concentrators: Market Shares, Strategies, and Forecasts, Worldwide 2017 - 2023" report from Wintergreen Research, Inc has been added to Research and Markets' offering. Stationary oxygen...
Cardax, Inc. (OTCQB:CDXI) welcomes the findings of a clinical study recently published in the New England Journal of Medicine that validate the crucial role inflammation plays in cardiovascular health. The 10,000 patient,...
Cardax, Inc. (OTCQB:CDXI) welcomes the findings of a clinical study recently published in the New England Journal of Medicine that validate the crucial role inflammation plays in cardiovascular health. The 10,000 patient,...
Enteris BioPharma, Inc., a biotechnology company developing innovative drug products built around its proprietary delivery technologies, today announced that Joel Tune, Chief Executive Officer and Executive Chairman of...
Enteris BioPharma, Inc., a biotechnology company developing innovative drug products built around its proprietary delivery technologies, today announced that Joel Tune, Chief Executive Officer and Executive Chairman of...
Sorrento Therapeutics, Inc. (NASDAQ: SRNE, "Sorrento"), announced today that it will participate in the Cantor Global Healthcare Conference, taking place in New York City (Intercontinental NY Barclay Hotel).
Sorrento Therapeutics, Inc. (NASDAQ: SRNE, "Sorrento"), announced today that it will participate in the Cantor Global Healthcare Conference, taking place in New York City (Intercontinental NY Barclay Hotel).
Edico Genome today announced the availability of its DRAGENTM Bio-IT Platform on Illumina's BaseSpace® Sequence Hub, enabling users to now run DRAGEN instances to enhance the accuracy and speed of their secondary...
Edico Genome today announced the availability of its DRAGENTM Bio-IT Platform on Illumina's BaseSpace® Sequence Hub, enabling users to now run DRAGEN instances to enhance the accuracy and speed of their secondary...
Oncotarget, a distinguished multidisciplinary bio-medical journal, reassured readers this week that all of its scientific publications are and will continue to be available on PubMed, PubMed Central, ISI/Web of Science:...
Oncotarget, a distinguished multidisciplinary bio-medical journal, reassured readers this week that all of its scientific publications are and will continue to be available on PubMed, PubMed Central, ISI/Web of Science:...
For over 17 years, the highly-coveted Allure Best of Beauty Breakthrough Awards have recognized hair, makeup and skin products, fragrances and devices for their innovative formulations, performance and technologies....
For over 17 years, the highly-coveted Allure Best of Beauty Breakthrough Awards have recognized hair, makeup and skin products, fragrances and devices for their innovative formulations, performance and technologies....
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Raul Rodriguez, the company's president and chief executive officer, is scheduled to present a company overview at the Cantor Fitzgerald Global Healthcare...
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Raul Rodriguez, the company's president and chief executive officer, is scheduled to present a company overview at the Cantor Fitzgerald Global Healthcare...
ValGenesis Inc., the global leader in Enterprise Validation Lifecycle Management Solutions (VLMS) is pleased to announce the strategic partnership with VTI Life Sciences (VTI). This partnership enables VTI to provide...
ValGenesis Inc., the global leader in Enterprise Validation Lifecycle Management Solutions (VLMS) is pleased to announce the strategic partnership with VTI Life Sciences (VTI). This partnership enables VTI to provide...
BERG, a biopharmaceutical company that merges biology with technology to map the nature of diseases, today announced the completion of clinical validation for a new predictive diagnostic test that can improve detection of...
BERG, a biopharmaceutical company that merges biology with technology to map the nature of diseases, today announced the completion of clinical validation for a new predictive diagnostic test that can improve detection of...
Regen BioPharma Inc. (OTCQB: RGBP) and (OTCQB: RGBPP) President Dr. Harry Lander issued the following fiscal year end shareholder letter: As the end of Regen's fiscal year 2017 approaches on September 30th, I would...
Regen BioPharma Inc. (OTCQB: RGBP) and (OTCQB: RGBPP) President Dr. Harry Lander issued the following fiscal year end shareholder letter: As the end of Regen's fiscal year 2017 approaches on September 30th, I would...
Clinical trials evaluating PMN310 expected to initiate in 2019
Clinical trials evaluating PMN310 expected to initiate in 2019
Agena Bioscience, a global provider of molecular genetic solutions and Molecular Health, a leader in cloud-based decision support technology for precision medicine, have entered into a strategic partnership, whereby...
Agena Bioscience, a global provider of molecular genetic solutions and Molecular Health, a leader in cloud-based decision support technology for precision medicine, have entered into a strategic partnership, whereby...
RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant unmet medical needs, announced today that Dr. Gerrit Dispersyn, RXi's Chief...
RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant unmet medical needs, announced today that Dr. Gerrit Dispersyn, RXi's Chief...
Dr. Andres Gutierrez, Oncolytics' Chief Medical Officer, to present on the clinical progress and robust safety findings of using reovirus as an immuno-oncology viral agent to treat cancer
Dr. Andres Gutierrez, Oncolytics' Chief Medical Officer, to present on the clinical progress and robust safety findings of using reovirus as an immuno-oncology viral agent to treat cancer
PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that John P. McLaughlin, PDL's chief executive officer, will present at the 2017 Cantor Fitzgerald Global Healthcare Conference in New York City on Tuesday,...
PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that John P. McLaughlin, PDL's chief executive officer, will present at the 2017 Cantor Fitzgerald Global Healthcare Conference in New York City on Tuesday,...
Jonah's Just Begun-Foundation to Cure Sanfilippo Inc. (JJB) announces the launch of "Mission Hide and Help" (https://missionhideandhelp.org), a social media campaign designed to reach parents; their pediatric and early...
Jonah's Just Begun-Foundation to Cure Sanfilippo Inc. (JJB) announces the launch of "Mission Hide and Help" (https://missionhideandhelp.org), a social media campaign designed to reach parents; their pediatric and early...
Agenus Inc. (NASDAQ: AGEN), an immune-oncology company with a pipeline of immune checkpoint antibodies and cancer vaccines, announced today that members of the Company's Leadership will present and host one-on-one...
Agenus Inc. (NASDAQ: AGEN), an immune-oncology company with a pipeline of immune checkpoint antibodies and cancer vaccines, announced today that members of the Company's Leadership will present and host one-on-one...
Following the devastating damage caused by recent hurricanes, CVS Health (NYSE: CVS) today launched an in-store customer donation campaign to support the rebuilding efforts underway in the impacted areas. As part of this...
Following the devastating damage caused by recent hurricanes, CVS Health (NYSE: CVS) today launched an in-store customer donation campaign to support the rebuilding efforts underway in the impacted areas. As part of this...
Pfenex Inc. (NYSE MKT: PFNX) announced today that it will be presenting at the Cantor Fitzgerald Global Healthcare Conference on September 27th, 2017 at 4:00 pm ET. The conference will be held at the Intercontinental New...
Pfenex Inc. (NYSE MKT: PFNX) announced today that it will be presenting at the Cantor Fitzgerald Global Healthcare Conference on September 27th, 2017 at 4:00 pm ET. The conference will be held at the Intercontinental New...
Eugen Trinka, Mar Carreño, European Neurological Review, 2017;12(1):17-23 DOI: https://doi.org/10.17925/ENR.2017.12.01.17 (Logo: http://mma.prnewswire.com/media/515766/Touch_Medical_Logo.jpg ) Published recently in...
Eugen Trinka, Mar Carreño, European Neurological Review, 2017;12(1):17-23 DOI: https://doi.org/10.17925/ENR.2017.12.01.17 (Logo: http://mma.prnewswire.com/media/515766/Touch_Medical_Logo.jpg ) Published recently in...
If you want a Stock Review on XON, AMPE, APHB, or CRMD then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. On Monday, the NASDAQ Composite ended the day at 6,454.64,...
If you want a Stock Review on XON, AMPE, APHB, or CRMD then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. On Monday, the NASDAQ Composite ended the day at 6,454.64,...
Sepsis is the primary cause of death from infection worldwide, with over 18 million cases per year, and represents the most costly condition treated within hospitals in the United States, hitting 20 billion dollars in 2011...
Sepsis is the primary cause of death from infection worldwide, with over 18 million cases per year, and represents the most costly condition treated within hospitals in the United States, hitting 20 billion dollars in 2011...
Disarm Therapeutics, a new biotechnology company developing therapeutics to treat patients with neurological diseases by preventing axonal degeneration, today announced the recent completion of a $30 million Series A...
Disarm Therapeutics, a new biotechnology company developing therapeutics to treat patients with neurological diseases by preventing axonal degeneration, today announced the recent completion of a $30 million Series A...
Sustained safety observed over 48 weeks of treatmentBeneficial clinical effects in liver sustained over 48 weeks of treatmentPositive results support requests for meetings with both FDA and EMA to define the...
Sustained safety observed over 48 weeks of treatmentBeneficial clinical effects in liver sustained over 48 weeks of treatmentPositive results support requests for meetings with both FDA and EMA to define the...
The global cell counting market is expected to reach USD 1.7 billion by 2025, according to a new report by Grand View Research, Inc. Government initiatives working to promote development of cell therapeutics, wherein cell...
The global cell counting market is expected to reach USD 1.7 billion by 2025, according to a new report by Grand View Research, Inc. Government initiatives working to promote development of cell therapeutics, wherein cell...
Today, Doctrina, an independent e-learning platform for pharmacists, pharmacy technicians and other healthcare professionals, has released a special white paper on the transformation of the pharma industry due to changes...
Today, Doctrina, an independent e-learning platform for pharmacists, pharmacy technicians and other healthcare professionals, has released a special white paper on the transformation of the pharma industry due to changes...
Indivumed GmbH (Indivumed) and Helomics® Corporation (Helomics) announce their intentions to collaborate to analyze human cancer biospecimens and annotated clinical data from consenting patients around the world, enabling...
Indivumed GmbH (Indivumed) and Helomics® Corporation (Helomics) announce their intentions to collaborate to analyze human cancer biospecimens and annotated clinical data from consenting patients around the world, enabling...
CSE: IN OTCQB: IMLFF
CSE: IN OTCQB: IMLFF
As previously predicted, Ocrevus trial and share has increased significantly, positioning the new market entrant as second only to Biogen's Tysabri in the mAb DMT class, according to the most recent quarterly update by...
As previously predicted, Ocrevus trial and share has increased significantly, positioning the new market entrant as second only to Biogen's Tysabri in the mAb DMT class, according to the most recent quarterly update by...
GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced that the US Food and Drug Administration (FDA) has approved once-daily, single inhaler triple therapy fluticasone...
GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced that the US Food and Drug Administration (FDA) has approved once-daily, single inhaler triple therapy fluticasone...
Applied BioMath (www.appliedbiomath.com), the industry-leader in applying mechanistic modeling to drug research and development, today announced their participation in FierceBiotech's second Drug Development Forum...
Applied BioMath (www.appliedbiomath.com), the industry-leader in applying mechanistic modeling to drug research and development, today announced their participation in FierceBiotech's second Drug Development Forum...
MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing proprietary human placental tissue allografts, announced today that the...
MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing proprietary human placental tissue allografts, announced today that the...
This Spring StemCyte will mark its 20th anniversary as a global leader in the cord blood therapeutic industry. To honor all of its incredible accomplishments of the past 20 years, StemCyte will host a "Grand Open House"...
This Spring StemCyte will mark its 20th anniversary as a global leader in the cord blood therapeutic industry. To honor all of its incredible accomplishments of the past 20 years, StemCyte will host a "Grand Open House"...
On Sunday, September 24, 2017, Hyundai Hope On Wheels® will present Dana-Farber Cancer Institute with a total of $400,000 from the Hyundai Scholar Hope and Young Investigator grant. The grant funds will support the...
On Sunday, September 24, 2017, Hyundai Hope On Wheels® will present Dana-Farber Cancer Institute with a total of $400,000 from the Hyundai Scholar Hope and Young Investigator grant. The grant funds will support the...
On Wednesday, September 20, 2017, Hyundai Hope On Wheels® will present Children's Hospital of Pittsburgh of UPMC with a $250,000 Hyundai Scholar Hope Grant. The grant funds will support the research of principal...
On Wednesday, September 20, 2017, Hyundai Hope On Wheels® will present Children's Hospital of Pittsburgh of UPMC with a $250,000 Hyundai Scholar Hope Grant. The grant funds will support the research of principal...
SMITHS FALLS, ON, Sept. 18, 2017 /CNW/ - Canopy Growth Corporation (TSX: WEED) ("Canopy Growth" or the "Company") is proud to introduce Spectrum Cannabis to the Canadian medical cannabis market.
SMITHS FALLS, ON, Sept. 18, 2017 /CNW/ - Canopy Growth Corporation (TSX: WEED) ("Canopy Growth" or the "Company") is proud to introduce Spectrum Cannabis to the Canadian medical cannabis market.
Thrombolytic Science, LLC (TSI), a clinical stage vascular health and biotechnology company, today announced the completion of a Phase 1 clinical trial of TS01, a new-generation clot-dissolving therapy aimed at the...
Thrombolytic Science, LLC (TSI), a clinical stage vascular health and biotechnology company, today announced the completion of a Phase 1 clinical trial of TS01, a new-generation clot-dissolving therapy aimed at the...
Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological...
Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological...
Joslin Diabetes Center, the world's preeminent diabetes care and research center, today announced it has signed an agreement with China Horae Capital Management Group Co., Ltd. to advise the Horae Nanjing Diabetes...
Joslin Diabetes Center, the world's preeminent diabetes care and research center, today announced it has signed an agreement with China Horae Capital Management Group Co., Ltd. to advise the Horae Nanjing Diabetes...
Symic Bio, a biopharmaceutical company developing novel matrix regulators, today announced that Ken Horne, Chief Executive Officer, will present an overview of the company pipeline at the Ladenburg Thalmann 2017 Healthcare...
Symic Bio, a biopharmaceutical company developing novel matrix regulators, today announced that Ken Horne, Chief Executive Officer, will present an overview of the company pipeline at the Ladenburg Thalmann 2017 Healthcare...
According to a recent report by New Frontier Data, the Viridian Cannabis Stock Index gained 236.1% in 2016 and outperforming such mainstream indexes as the Russell 2000 (up 19.5%), the Dow Jones Industrial Average (up...
According to a recent report by New Frontier Data, the Viridian Cannabis Stock Index gained 236.1% in 2016 and outperforming such mainstream indexes as the Russell 2000 (up 19.5%), the Dow Jones Industrial Average (up...
MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts with patent-protected processes for...
MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts with patent-protected processes for...
Menlo Therapeutics Inc. announced today the presentation of data from two phase 2 clinical studies of serlopitant at the 2017 EADV conference, the leading annual dermatology meeting in Europe. A 257-patient phase 2 trial...
Menlo Therapeutics Inc. announced today the presentation of data from two phase 2 clinical studies of serlopitant at the 2017 EADV conference, the leading annual dermatology meeting in Europe. A 257-patient phase 2 trial...
CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced today that Pat Mackin, Chairman, President and Chief Executive Officer, will present at...
CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced today that Pat Mackin, Chairman, President and Chief Executive Officer, will present at...
